We are live on ! Find out more
AC

Amia Capital Portfolio holdings

AUM $32.1M
1-Year Est. Return 0.56%
This Fund
S&P 500
This Quarter Est. Return
+13.17%
1 Year Est. Return
+0.56%
3 Year Est. Return
+30.11%
5 Year Est. Return
10 Year Est. Return
AUM
$343M
AUM Growth
Cap. Flow
+$327M
Cap. Flow %
95.33%
Top 10 Hldgs %
88.26%
Holding
41
New
41
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 26.19%
2 Energy 3.72%
3 Communication Services 3.4%
4 Materials 3.08%
5 Consumer Discretionary 0.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSXMA
1
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$74.6M 21.75%
+2,135,607
New +$70.6M
EMB icon
2
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$67.2M 19.59%
+586,300
New +$66.2M
GRFS
3
Grifois
GRFS
$5.18B
$50.3M 14.65%
+2,157,906
New +$47M
LSXMK
4
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$46.3M 13.51%
+1,263,181
New +$44.1M
BBL
5
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$18.4M 5.38%
+392,128
New +$17.2M
PBR icon
6
Petrobras
PBR
$119B
$12.8M 3.72%
+800,000
New +$12.2M
LILA icon
7
Liberty Latin America Class A
LILA
$1.48B
$11.7M 3.4%
+944,211
New +$11M
VALE icon
8
Vale
VALE
$60.6B
$10.6M 3.08%
+800,000
New +$9.61M
IONS icon
9
Ionis Pharmaceuticals
IONS
$8.82B
$5.59M 1.63%
+92,512
New +$5.51M
IBB icon
10
iShares Biotechnology ETF
IBB
$9.37B
$5.36M 1.56%
+44,439
New +$4.96M
NBIX icon
11
Neurocrine Biosciences
NBIX
$18B
$3.74M 1.09%
+34,772
New +$3.64M
INCY icon
12
Incyte
INCY
$23.5B
$3.49M 1.02%
+40,017
New +$3.42M
VRTX icon
13
Vertex Pharmaceuticals
VRTX
$122B
$3.15M 0.92%
+14,397
New +$2.91M
ECH icon
14
iShares MSCI Chile ETF
ECH
$1.03B
$3M 0.87%
+90,000
New +$3.09M
ESPR
15
DELISTED
Esperion Therapeutics
ESPR
$2.42M 0.71%
+40,563
New +$1.82M
QGEN icon
16
Qiagen
QGEN
$8.36B
$2.34M 0.68%
+64,937
New +$2.41M
ALNY icon
17
Alnylam Pharmaceuticals
ALNY
$36.4B
$2.06M 0.6%
+17,903
New +$1.78M
AGIO icon
18
Agios Pharmaceuticals
AGIO
$2.38B
$1.88M 0.55%
+39,270
New +$1.48M
ARGX icon
19
argenx
ARGX
$54.7B
$1.61M 0.47%
+10,020
New +$1.36M
ALXN
20
DELISTED
Alexion Pharmaceuticals
ALXN
$1.61M 0.47%
+14,846
New +$1.59M
HALO icon
21
Halozyme
HALO
$9.14B
$1.59M 0.46%
+89,573
New +$1.55M
RDUS
22
DELISTED
Radius Health, Inc.
RDUS
$1.52M 0.44%
+75,599
New +$1.84M
LEN.B icon
23
Lennar Class B
LEN.B
$19.6B
$1.44M 0.42%
+33,945
New +$1.51M
MRNA icon
24
Moderna
MRNA
$23.7B
$1.04M 0.3%
+53,076
New +$942K
SAGE
25
DELISTED
Sage Therapeutics
SAGE
$1.01M 0.3%
+14,041
New +$1.73M

Similar funds

Amia Capital's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Amia Capital, which disclosed 41 positions worth $343M. Its ten largest holdings account for 88% of the portfolio.

Its largest position is Liberty Media Corporation Series A Liberty SiriusXM Common Stock: 2,135,607 shares worth $74.6M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, followed by Energy and Communication Services.

  • Amia Capital's largest Q4 2019 buy was Liberty Media Corporation Series A Liberty SiriusXM Common Stock: 2,135,607 shares worth $74.6M.
  • Amia Capital's ten largest holdings make up 88% of its $343M portfolio in Q4 2019.
  • Amia Capital disclosed 41 positions in Q4 2019, its first 13F filing on record.

Based on Amia Capital's 13F filing for Q4 2019, filed 13 Feb 2020.